Cathay Biotech Inc. (SHA:688065)
China · Delayed Price · Currency is CNY 48.11
+0.37 (0.78%)
Apr 30, 2026, 3:00 PM CST
Cathay Biotech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 529.5 | 488.96 | 366.52 | 553.27 | 594.72 |
Depreciation & Amortization | 315.59 | 315.92 | 285.72 | 265.12 | 168.54 |
Other Amortization | 3.37 | 9.54 | 3.88 | 4.68 | 3.68 |
Loss (Gain) From Sale of Assets | -6.71 | -0.4 | 0.01 | -0.05 | - |
Asset Writedown & Restructuring Costs | 135.73 | 0.04 | 4.93 | 36.22 | 10.69 |
Loss (Gain) From Sale of Investments | -1.4 | 8.95 | 7.82 | 3.71 | -16.3 |
Provision & Write-off of Bad Debts | - | 3.34 | -6.27 | - | - |
Other Operating Activities | 98.16 | 72.6 | 76.88 | -3.57 | 25.36 |
Change in Accounts Receivable | -382.67 | -246.25 | -320.06 | 24.8 | -224.95 |
Change in Inventory | -395.29 | 198.51 | 78.3 | -418.06 | -282.62 |
Change in Accounts Payable | 174.79 | 22.48 | 133.66 | 355.46 | 310.02 |
Change in Other Net Operating Assets | 0.8 | -1.26 | 8.65 | 18.18 | 6.47 |
Operating Cash Flow | 404.12 | 820.93 | 569.45 | 803.67 | 578.69 |
Operating Cash Flow Growth | -50.77% | 44.16% | -29.14% | 38.88% | 12.37% |
Capital Expenditures | -743.46 | -843.31 | -1,570 | -4,198 | -1,459 |
Sale of Property, Plant & Equipment | 35.16 | 20.25 | 142.01 | 0.14 | - |
Investment in Securities | -25.5 | - | -101.04 | - | 1,320 |
Other Investing Activities | 7.92 | - | -30 | - | 28.42 |
Investing Cash Flow | -725.88 | -823.06 | -1,559 | -4,198 | -110.76 |
Long-Term Debt Issued | 758.4 | 1,889 | 937.02 | 1,126 | 798.08 |
Long-Term Debt Repaid | -2,126 | -1,570 | -289.77 | -740 | -55 |
Total Debt Repaid | -2,126 | -1,570 | -289.77 | -740 | -55 |
Net Debt Issued (Repaid) | -1,367 | 319.26 | 647.25 | 386.47 | 743.08 |
Issuance of Common Stock | 5,915 | - | 4.17 | 4.52 | - |
Repurchase of Common Stock | - | -28.93 | -31.52 | -94.67 | - |
Common Dividends Paid | -313.13 | -140.83 | -137.75 | -206.85 | -339.63 |
Dividends Paid | -313.13 | -140.83 | -137.75 | -206.85 | -339.63 |
Other Financing Activities | 80.91 | - | -744.31 | 314.41 | 2,584 |
Financing Cash Flow | 4,315 | 149.49 | -262.16 | 403.88 | 2,987 |
Foreign Exchange Rate Adjustments | -58.92 | 24.82 | 40.22 | 59.98 | -9.19 |
Net Cash Flow | 3,935 | 172.19 | -1,211 | -2,931 | 3,446 |
Free Cash Flow | -339.34 | -22.38 | -1,000 | -3,395 | -880.49 |
Free Cash Flow Margin | -10.30% | -0.76% | -47.32% | -139.06% | -37.25% |
Free Cash Flow Per Share | -0.50 | -0.04 | -1.72 | -5.83 | -1.51 |
Cash Income Tax Paid | 289.25 | 229.15 | 90.88 | -281.56 | -12.97 |
Levered Free Cash Flow | -384.12 | -418.14 | -567.98 | -3,302 | -1,301 |
Unlevered Free Cash Flow | -384.12 | -400.99 | -547.87 | -3,290 | -1,290 |
Change in Working Capital | -670.13 | -78.01 | -170.04 | -55.7 | -208 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.